|
ZA811368B
(en)
|
1980-03-24 |
1982-04-28 |
Genentech Inc |
Bacterial polypedtide expression employing tryptophan promoter-operator
|
|
JPS62501537A
(ja)
*
|
1984-12-21 |
1987-06-25 |
テクニクロン・リサ−チ・パ−トナ−ズ・ワン |
リンパ球細胞を電気的に不滅化するための方法
|
|
DE3531430A1
(de)
|
1985-09-03 |
1987-03-05 |
Biotest Pharma Gmbh |
Verfahren zur gewinnung von komponenten aus einer fluessigkeit mit in raeumlich getrennten bereichen vorliegenden komponenten
|
|
US4963489A
(en)
*
|
1987-04-14 |
1990-10-16 |
Marrow-Tech, Inc. |
Three-dimensional cell and tissue culture system
|
|
US4900322A
(en)
|
1986-09-22 |
1990-02-13 |
Adams James D |
Blood component pooling valve and kit
|
|
US5476996A
(en)
*
|
1988-06-14 |
1995-12-19 |
Lidak Pharmaceuticals |
Human immune system in non-human animal
|
|
US5399493A
(en)
|
1989-06-15 |
1995-03-21 |
The Regents Of The University Of Michigan |
Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
|
|
US5804604A
(en)
|
1989-12-21 |
1998-09-08 |
Biogen, Inc. |
Tat-derived transport polypeptides and fusion proteins
|
|
US5670617A
(en)
|
1989-12-21 |
1997-09-23 |
Biogen Inc |
Nucleic acid conjugates of tat-derived transport polypeptides
|
|
US5849288A
(en)
*
|
1990-01-15 |
1998-12-15 |
Yeda Research And Development Co. Ltd. |
Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells
|
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
|
US5843728A
(en)
|
1991-03-07 |
1998-12-01 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
|
US5851828A
(en)
|
1991-03-07 |
1998-12-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
|
US5912170A
(en)
|
1991-03-07 |
1999-06-15 |
The General Hospital Corporation |
Redirection of cellular immunity by protein-tyrosine kinase chimeras
|
|
US6004811A
(en)
|
1991-03-07 |
1999-12-21 |
The Massachussetts General Hospital |
Redirection of cellular immunity by protein tyrosine kinase chimeras
|
|
IE920716A1
(en)
|
1991-03-07 |
1992-09-09 |
Gen Hospital Corp |
Redirection of cellular immunity by receptor chimeras
|
|
US6753162B1
(en)
|
1991-03-07 |
2004-06-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
|
AU781922B2
(en)
|
1991-12-17 |
2005-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5289858A
(en)
|
1991-12-18 |
1994-03-01 |
Abbott Laboratories |
System for accommodating withdrawal of liquid from a bulk supply
|
|
US8211422B2
(en)
|
1992-03-18 |
2012-07-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric receptor genes and cells transformed therewith
|
|
EP0903408A3
(en)
|
1992-08-21 |
2005-11-02 |
Biogen, Inc. |
Tat-derived transport polypeptide
|
|
US5580760A
(en)
|
1993-02-22 |
1996-12-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
FUSE binding protein and cDNA therefor
|
|
WO1995003402A1
(en)
*
|
1993-07-22 |
1995-02-02 |
Merck & Co., Inc. |
EXPRESSION OF HUMAN INTERLEUKIN-1β IN A TRANSGENIC ANIMAL
|
|
US5599705A
(en)
*
|
1993-11-16 |
1997-02-04 |
Cameron; Robert B. |
In vitro method for producing differentiated universally compatible mature human blood cells
|
|
CA2184356A1
(en)
|
1994-03-03 |
1995-09-08 |
Russell P. Rother |
Terminal complement inhibitor fusion genes and proteins
|
|
US5827642A
(en)
|
1994-08-31 |
1998-10-27 |
Fred Hutchinson Cancer Research Center |
Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
|
|
US6713247B1
(en)
*
|
1996-09-03 |
2004-03-30 |
Signal Pharmaceuticials, Inc. |
Human CNS cell lines and methods of use therefor
|
|
ES2210761T3
(es)
|
1997-05-21 |
2004-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Composicion y procedimiento para mejorar el transporte a traves de las membranas biologicas.
|
|
EP0893493A3
(de)
*
|
1997-07-21 |
2002-12-04 |
Aventis Pharma Deutschland GmbH |
Genetisch veränderte Zellen und deren Verwendung in der Prophylaxe oder Therapie von Erkrankungen
|
|
GB9720585D0
(en)
|
1997-09-26 |
1997-11-26 |
Smithkline Beecham Biolog |
Vaccine
|
|
CA2314267A1
(en)
|
1997-12-10 |
1999-06-17 |
Washington University |
Anti-pathogen system and methods of use thereof
|
|
ATE288477T1
(de)
|
1998-04-08 |
2005-02-15 |
Shionogi & Co |
Verfahren um vorläuferzellen von osteoklasten zu isolieren und ihre differenzierung in osteoklasten zu induzieren.
|
|
US6835567B1
(en)
*
|
1998-04-14 |
2004-12-28 |
Signal Pharmaceuticals, Inc. |
PNS cell lines and methods of use therefor
|
|
US6451558B1
(en)
*
|
1998-08-03 |
2002-09-17 |
Novartis Ag |
Genes in the control of hematopoiesis
|
|
US6913925B1
(en)
*
|
1998-08-12 |
2005-07-05 |
Signal Pharmaceuticals Llc |
Human mesencephalon cell lines and methods of use therefor
|
|
AU7497000A
(en)
|
1999-02-28 |
2000-11-14 |
Washington University |
Novel transduction molecules and methods for using same
|
|
WO2000059540A1
(en)
|
1999-04-05 |
2000-10-12 |
Biocrystal Ltd. |
Assay kits and methods for immune complex-mediated activation involving shed antigens
|
|
US6358739B1
(en)
|
1999-04-12 |
2002-03-19 |
Modex Therapeutiques, S.A. |
Transiently immortalized cells
|
|
US6451601B1
(en)
*
|
1999-04-12 |
2002-09-17 |
Modex Therapeutiques, S.A. |
Transiently immortalized cells for use in gene therapy
|
|
EP1175436B1
(en)
*
|
1999-04-12 |
2006-10-11 |
Heart Biosystems GmbH |
Transiently immortalized cells for use in gene therapy
|
|
US7135287B1
(en)
*
|
1999-10-02 |
2006-11-14 |
Biosite, Inc. |
Human antibodies
|
|
US7311920B1
(en)
*
|
1999-10-08 |
2007-12-25 |
University Of Maryland Biotechnology Institute |
Virus coat protein/receptor chimeras and methods of use
|
|
CA2390011A1
(en)
|
1999-11-10 |
2001-05-17 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions comprising renilla gfp
|
|
EP1103615A1
(en)
|
1999-11-25 |
2001-05-30 |
Universite De Geneve |
Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
|
|
US20010049393A1
(en)
*
|
1999-12-07 |
2001-12-06 |
Whitehead Institute For Biomedical Research |
Methods for defining MYC target genes and uses thereof
|
|
AU2001256746A1
(en)
*
|
2000-05-15 |
2001-11-26 |
Sonoko Habu |
Chimeric mouse having immunity constructed by using human cd34-positive cells and use thereof
|
|
US20020155127A1
(en)
|
2000-06-02 |
2002-10-24 |
Danher Wang |
Genetic vaccine against human immunodeficiency virus
|
|
US20030072794A1
(en)
*
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
|
US20070248618A1
(en)
*
|
2004-03-16 |
2007-10-25 |
Cohen David I |
Tat-Based vaccine Compositions and Methods of Making and Using Same
|
|
AU2001296354A1
(en)
|
2000-09-25 |
2002-04-02 |
Baylor College Of Medicine |
Improved system for regulation of transgene expression
|
|
US20020155502A1
(en)
|
2000-10-30 |
2002-10-24 |
Horizon Biotechnologies, Inc. |
Affinity maturation by competitive selection
|
|
US20040241140A1
(en)
|
2000-11-01 |
2004-12-02 |
Pavlakis George N. |
Expression vectors able to elicit improved immune response and methods of using same
|
|
DE60131676T2
(de)
*
|
2000-12-01 |
2008-10-30 |
Central Institute For Experimental Animals |
Verfahren zur herstellung einer maus, die für die aufnahme, differenzierung und proliferation von heterogenen zellen geeignet ist, die hierdurch hergestellte maus und ihre verwendung
|
|
WO2002057436A2
(en)
|
2001-01-19 |
2002-07-25 |
Gendel Limited |
Red blood cell from a transgenic animal as vehicle for polypeptide delivery
|
|
US7033744B2
(en)
|
2001-03-16 |
2006-04-25 |
Naoya Kobayashi |
Method for proliferating a liver cell, a liver cell obtained thereby, and use thereof
|
|
WO2002097050A2
(en)
*
|
2001-05-31 |
2002-12-05 |
Novartis Ag |
Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
|
|
PT1421115E
(pt)
|
2001-08-31 |
2005-07-29 |
Avidex Ltd |
Receptor de celulas t soluvel
|
|
CN1408850A
(zh)
*
|
2001-09-18 |
2003-04-09 |
王虹 |
人血树突状细胞永生化技术
|
|
CN100506978C
(zh)
|
2001-09-21 |
2009-07-01 |
中国人民解放军军事医学科学院野战输血研究所 |
一种新的造血干/祖细胞的富集方法及其体外定向诱导分化
|
|
GB0124391D0
(en)
|
2001-10-11 |
2001-11-28 |
Gene Expression Technologies L |
Control of gene expression
|
|
JP2005508171A
(ja)
|
2001-11-02 |
2005-03-31 |
タノックス インコーポレーテッド |
Ｂ細胞悪性病変の診断及び予防に用いるためのｂ細胞リンパ腫特異抗原
|
|
EP1321034A1
(en)
*
|
2001-12-21 |
2003-06-25 |
Pfizer Products Inc. |
Disruption of the phosphodieterase 10 gene
|
|
WO2003057171A2
(en)
|
2002-01-03 |
2003-07-17 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of t-cells using an engineered multivalent signaling platform
|
|
US7745140B2
(en)
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
AU2003216288B2
(en)
|
2002-02-13 |
2009-09-24 |
Duke University |
Modulation of immune response by non-peptide binding stress response polypeptides
|
|
CN1240439C
(zh)
|
2002-03-28 |
2006-02-08 |
南京凯基生物科技发展有限公司 |
肿瘤基因开关药物
|
|
US7211191B2
(en)
|
2004-09-30 |
2007-05-01 |
Thermogenesis Corp. |
Blood component separation method and apparatus
|
|
JP2005523012A
(ja)
*
|
2002-04-16 |
2005-08-04 |
デイナ−ファーバー キャンサー インスティチュート，インコーポレイテッド |
癌モデル
|
|
GB2387599B
(en)
*
|
2002-04-17 |
2005-08-10 |
Jason Peter Brown |
Methods for producing antibodies
|
|
US7097841B2
(en)
*
|
2002-05-10 |
2006-08-29 |
New Century Pharmaceuticals, Inc. |
Ferritin fusion proteins for use in vaccines and other applications
|
|
CN1325512C
(zh)
*
|
2002-05-16 |
2007-07-11 |
巴法里安诺迪克有限公司 |
Hiv调节/辅助蛋白的融合蛋白
|
|
CA2485939C
(en)
*
|
2002-05-29 |
2013-10-29 |
Regeneron Pharmaceuticals, Inc. |
Inducible eukaryotic expression system
|
|
US8034334B2
(en)
|
2002-09-06 |
2011-10-11 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
|
|
AU2003271904B2
(en)
|
2002-10-09 |
2009-03-05 |
Adaptimmune Limited |
Single chain recombinant T cell receptors
|
|
EP1408114B1
(de)
*
|
2002-10-11 |
2007-01-03 |
Imvision GmbH |
Moduläre Antigen-Transporter Moleküle (MAT-Moleküle) zur Modulierung von Immunreaktionen, zugehörige Konstrukte, Verfahren und Verwendungen
|
|
US20060154331A1
(en)
*
|
2002-10-15 |
2006-07-13 |
Nili Avidan |
Erythrocyte differentiation factor, gene encoding same, and methods of use thereof
|
|
EP2048159B1
(en)
|
2002-11-09 |
2014-01-01 |
Immunocore Ltd. |
T cell receptor display
|
|
CA2508052A1
(en)
|
2002-12-05 |
2004-06-17 |
Imperial College Innovations Limited |
Control of apoptosis using a complex of an oligonucleotide and a regulatory peptide
|
|
GB0304068D0
(en)
|
2003-02-22 |
2003-03-26 |
Avidex Ltd |
Substances
|
|
WO2004084805A2
(en)
|
2003-03-19 |
2004-10-07 |
The J. David Gladstone Institutes |
Acetylated tat polypeptides and methods of use thereof
|
|
WO2004104185A1
(en)
|
2003-05-08 |
2004-12-02 |
Xcyte Therapies, Inc. |
Generation and isolation of antigen-specific t cells
|
|
WO2005014785A2
(en)
|
2003-06-18 |
2005-02-17 |
The George Washington University |
Conditionally-immortalized hematopoietic progenitor cell lines
|
|
US20060222657A1
(en)
|
2003-06-20 |
2006-10-05 |
Dowdy Steven F |
Polypeptide transduction and fusogenic peptides
|
|
IL161903A0
(en)
|
2003-07-17 |
2005-11-20 |
Gamida Cell Ltd |
Ex vivo progenitor and stem cell expansion for usein the treatment of disease of endodermally- deri ved organs
|
|
US7705049B2
(en)
*
|
2004-01-21 |
2010-04-27 |
New York University |
Methods for treating non-melanoma cancers with PABA
|
|
JP2005232148A
(ja)
|
2004-02-03 |
2005-09-02 |
Technion Research & Development Foundation Ltd |
神経保護剤としてプロパルギルアミンの使用
|
|
NZ550815A
(en)
|
2004-05-19 |
2009-04-30 |
Immunocore Ltd |
Method of improving T cell receptors
|
|
WO2005113595A2
(en)
|
2004-05-19 |
2005-12-01 |
Avidex Ltd |
High affinity ny-eso t cell receptor
|
|
EP1791865B1
(en)
|
2004-06-29 |
2010-07-28 |
Immunocore Ltd. |
Cells expressing a modified t cell receptor
|
|
US20060068469A1
(en)
|
2004-08-17 |
2006-03-30 |
Research Development Foundation |
Bacterial vector systems
|
|
GB0420963D0
(en)
|
2004-09-21 |
2004-10-20 |
Reneuron Ltd |
Hepatocyte
|
|
WO2006045064A2
(en)
*
|
2004-10-20 |
2006-04-27 |
Whitehead Institute For Biomedical Research |
Cultured hematopoietic stem cells and method for expansion and analysis thereof
|
|
WO2007067183A1
(en)
|
2005-12-09 |
2007-06-14 |
The Regents Of The University Of California |
Derivation of unlimited quantities of neutrophils or monocyte/dendritic cells
|
|
US20060156422A1
(en)
*
|
2005-01-10 |
2006-07-13 |
Medical Research Council |
Methods and compositions for the generation of antibodies
|
|
JP2008535823A
(ja)
|
2005-03-25 |
2008-09-04 |
キュラジェン コーポレイション |
テネイシンの主要な抗原に対する抗体
|
|
WO2006116512A1
(en)
|
2005-04-26 |
2006-11-02 |
The Board Of Trustees Of The University Of Illinois, Urbana, Il |
Nucleoside compounds and methods of use thereof
|
|
WO2006125962A2
(en)
|
2005-05-25 |
2006-11-30 |
Medigene Limited |
T cell receptors which specifically bind to vygfvracl-hla-a24
|
|
JP5276982B2
(ja)
*
|
2005-08-26 |
2013-08-28 |
ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
オキシトシンの投与による頭痛の処置のための方法
|
|
US20070047583A1
(en)
|
2005-08-29 |
2007-03-01 |
Siemens Aktiengesellschaft |
Method for using a short address in a packet header
|
|
US8883507B2
(en)
|
2005-10-18 |
2014-11-11 |
The Regents Of The University Of Colorado |
Conditionally immortalized long-term hematopoietic stem cells and methods of making and using such cells
|
|
AU2006311725B2
(en)
*
|
2005-11-04 |
2011-11-24 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for inhibiting expression of NAV1.8 gene
|
|
EP1792627A1
(en)
|
2005-12-05 |
2007-06-06 |
ImVisioN AG |
Modulation of the immune response by administration of intralymphatic transduction allergen (ITAG-)-molecules
|
|
WO2008039818A2
(en)
|
2006-09-26 |
2008-04-03 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Modified t cell receptors and related materials and methods
|
|
EP2087000A2
(en)
|
2006-09-29 |
2009-08-12 |
Immunocore Ltd. |
T cell therapies
|
|
CA2680613A1
(en)
|
2007-03-13 |
2008-09-18 |
National Jewish Medical And Research Center |
Methods for generation of antibodies
|
|
WO2009059304A2
(en)
|
2007-11-02 |
2009-05-07 |
Taiga Biotechnologies, Inc. |
Compounds for treating abnormal cellular proliferation
|
|
JP5951254B2
(ja)
|
2008-03-17 |
2016-07-13 |
ザ スクリプス リサーチ インスティテュート |
人工多能性幹細胞を作製するための化学的手法と遺伝的手法の組み合わせ法
|
|
SG10201803982TA
(en)
|
2008-05-16 |
2018-07-30 |
Taiga Biotechnologies Inc |
Antibodies and processes for preparing the same
|
|
EP2304035A2
(en)
|
2008-06-13 |
2011-04-06 |
Life & Brain GmbH |
Fusion protein and use thereof
|
|
DK2313496T3
(en)
|
2008-07-21 |
2014-12-15 |
Taiga Biotechnologies Inc |
Anukleære differentiated cells, and method for preparation thereof
|
|
US8784825B2
(en)
|
2008-08-28 |
2014-07-22 |
Taiga Biotechnologies, Inc. |
Modulators of MYC, methods of using the same, and methods of identifying agents that modulate MYC
|
|
EP3031907B1
(en)
|
2008-11-06 |
2021-01-06 |
Indiana University Research and Technology Corporation |
Materials and methods to enhance hematopoietic stem cells engraftment procedures
|
|
CN102272153B
(zh)
|
2008-11-24 |
2015-04-15 |
德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 |
高亲和力t细胞受体及其应用
|
|
WO2011100477A2
(en)
|
2010-02-10 |
2011-08-18 |
Taiga Biotechnologies, Inc. |
Antibodies and processes for preparing the same
|
|
US20120107317A1
(en)
|
2010-10-27 |
2012-05-03 |
The University Of Hong Kong |
Use of cytoplasmic c-myc for regulating immune responses
|
|
US20120244133A1
(en)
|
2011-03-22 |
2012-09-27 |
The United States of America, as represented by the Secretary, Department of Health and |
Methods of growing tumor infiltrating lymphocytes in gas-permeable containers
|
|
SI2755997T1
(sl)
|
2011-09-15 |
2018-11-30 |
The United States of America, as represented by Secretary, Department of Health and Human Services, Office of Technology Transfer, National Institutes of Health |
T-celični receptorji, ki prepoznajo HLA-A1- ali HLA-CW7-omejeni mage
|
|
NZ702108A
(en)
|
2012-05-03 |
2016-09-30 |
Hutchinson Fred Cancer Res |
Enhanced affinity t cell receptors and methods for making the same
|
|
DE102012209673A1
(de)
|
2012-06-08 |
2013-12-24 |
Artcline Gmbh |
Verfahren zum Herstellen einer Leukozytenpräparation und Leukozytenpräparation
|
|
JP6285930B2
(ja)
|
2012-07-20 |
2018-02-28 |
タイガ バイオテクノロジーズ，インク． |
造血コンパートメントの再構築及び自家再構築の増進
|
|
NZ741124A
(en)
|
2012-07-27 |
2019-11-29 |
Univ Illinois |
Engineering t-cell receptors
|
|
US20140109246A1
(en)
|
2012-09-24 |
2014-04-17 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods of generating xenochimaeric mice with tumor and hematopoietic system from the same heterologous species
|
|
GB2508414A
(en)
|
2012-11-30 |
2014-06-04 |
Max Delbrueck Centrum |
Tumour specific T cell receptors (TCRs)
|
|
JP6257655B2
(ja)
|
2013-03-01 |
2018-01-10 |
アメリカ合衆国 |
末梢血から腫瘍反応性ｔ細胞の濃縮された集団を作製する方法
|
|
WO2014133567A1
(en)
|
2013-03-01 |
2014-09-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of producing enriched populations of tumor-reactive t cells from tumor
|
|
US9365825B2
(en)
|
2013-03-11 |
2016-06-14 |
Taiga Biotechnologies, Inc. |
Expansion of adult stem cells in vitro
|
|
US10272115B2
(en)
|
2013-03-11 |
2019-04-30 |
Taiga Biotechnologies, Inc. |
Production and use of red blood cells
|
|
KR20160145186A
(ko)
|
2014-04-24 |
2016-12-19 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
입양 세포 요법 생성물을 생성하기 위한 유도 만능 줄기 세포의 응용
|
|
JP6743022B2
(ja)
|
2014-12-24 |
2020-08-19 |
ネクシミューン インコーポレイテッド |
免疫療法のためのナノ粒子組成物及び方法
|
|
EP3402814B1
(en)
|
2016-01-15 |
2021-04-21 |
Berkeley Lights, Inc. |
Methods of producing patient-specific anti-cancer therapeutics and methods of treatment therefor
|
|
US10149898B2
(en)
|
2017-08-03 |
2018-12-11 |
Taiga Biotechnologies, Inc. |
Methods and compositions for the treatment of melanoma
|